PERIOGARD MOUTHWASH
Country: Canada
Language: English
Source: Health Canada
Summary of Product characteristics
(SPC)
23-08-2017
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
CHLORHEXIDINE GLUCONATE
Available from:
COLGATE-PALMOLIVE CANADA INC
ATC code:
A01AB03
INN (International Name):
CHLORHEXIDINE
Dosage:
0.12%
Pharmaceutical form:
MOUTHWASH
Composition:
CHLORHEXIDINE GLUCONATE 0.12%
Administration route:
BUCCAL
Units in package:
473ML
Prescription type:
Prescription
Therapeutic area:
MISCELLANEOUS ANTI-INFECTIVES
Product summary:
Active ingredient group (AIG) number: 0107629007; AHFS:
Authorization status:
CANCELLED POST MARKET
Authorization date:
2022-03-30
Summary of Product characteristics
_Page 1 of 19_
PRODUCT MONOGRAPH
CHLORHEXIDINE GLUCONATE ORAL RINSE
Chlorhexidine Gluconate 0.12% Oral Rinse Liquid, USP
0.12% Chlorhexidine Gluconate Antigingivital Oral Rinse
Colgate-Palmolive Canada Inc.
Two Morneau Shepell Centre, 5
th
Floor,
895 Don Mills Road,
Toronto, Ontario
M3C 1W3
Submission Control No.: 207101
Date of Preparation:
August 17, 2017
_Page 2 of 19_
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL
INFORMATION.....................................................3
SUMMARY PRODUCT INFORMATION
................................................................3
INDICATIONS AND CLINICAL USE
......................................................................3
CONTRAINDICATIONS
.........................................................................................3
WARNINGS AND PRECAUTIONS
........................................................................4
ADVERSE
REACTIONS.........................................................................................6
DOSAGE AND ADMINISTRATION
........................................................................6
OVERDOSAGE
.....................................................................................................7
ACTION AND CLINICAL PHARMACOLOGY
........................................................8
STORAGE AND STABILITY
..................................................................................9
SPECIAL HANDLING INSTRUCTIONS
................................................................9
DOSAGE FORMS, COMPOSITION AND PACKAGING
.....................................10
PART II: SCIENTIFIC INFORMATION
..........................................................................11
PHARMACEUTICAL
INFORMATION..................................................................11
CLINICAL TRIALS
................................................................................................12
DETAILED PHARMACOLOGY
............................................................................13
MICROBIOLOGY
..............................
Read the complete document
